Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$435K Hold
1,235
0.07% 236
2025
Q4
$404K Hold
1,235
0.06% 255
2025
Q3
$349K Hold
1,235
0.05% 271
2025
Q2
$345K Hold
1,235
0.03% 287
2025
Q1
$385K Hold
1,235
0.04% 276
2024
Q4
$322K Hold
1,235
0.03% 300
2024
Q3
$398K Hold
1,235
0.04% 277
2024
Q2
$386K Hold
1,235
0.04% 269
2024
Q1
$351K Hold
1,235
0.03% 283
2023
Q4
$356K Hold
1,235
0.04% 294
2023
Q3
$332K Hold
1,235
0.04% 280
2023
Q2
$274K Hold
1,235
0.03% 302
2023
Q1
$299K Hold
1,235
0.04% 304
2022
Q4
$324K Hold
1,235
0.04% 307
2022
Q3
$278K Hold
1,235
0.05% 322
2022
Q2
$300K Hold
1,235
0.07% 285
2022
Q1
$299K Hold
1,235
0.06% 310
2021
Q4
$278K Hold
1,235
0.06% 331
2021
Q3
$263K Hold
1,235
0.06% 315
2021
Q2
$301K Hold
1,235
0.05% 350
2021
Q1
$307K Hold
1,235
0.06% 349
2020
Q4
$284K Hold
1,235
0.06% 350
2020
Q3
$314K Buy
1,235
+173
+16% +$42.9K 0.08% 323
2020
Q2
$250K Buy
1,062
+26
+3% +$5.93K 0.06% 377
2020
Q1
$210K Buy
+1,036
New +$226K 0.06% 352
2013
Q3
Sell
-22
Closed -$2K 607
2013
Q2
$2K Buy
+22
New +$2.28K ﹤0.01% 415

Other funds holding AMGN

Globeflex Capital's AMGN Position: Q1 2026 in Review

Globeflex Capital held its Amgen (AMGN) position steady in Q1 2026 at 1,235 shares worth $435K. The position accounts for 0.07% of the portfolio, ranked #236.

Globeflex Capital first reported a position in AMGN in Q2 2013 and has held it in 26 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Globeflex Capital held 1,235 shares of Amgen worth $435K as of Q1 2026.
  • Globeflex Capital left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.07% of Globeflex Capital's portfolio in Q1 2026, its #236 holding.
  • Globeflex Capital first reported a position in Amgen in Q2 2013 and has held it in 26 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.